Lataa...
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
Patients with pre-existing comorbidities and immunosuppression are at greater risk for SARS-CoV-2 infection and severe manifestations of COVID-19. This also includes cancer patients, who are shown to have a poor prognosis after infection. Here, we describe the case of a 72-year old male patient with...
Tallennettuna:
| Julkaisussa: | Front Oncol |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493633/ https://ncbi.nlm.nih.gov/pubmed/32984017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01578 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|